INFLAMACIÓN Y BIOMARCADORES
St. Michael's Hospital
Toronto, CanadáPublikationen in Zusammenarbeit mit Forschern von St. Michael's Hospital (2)
2020
-
A new risk variant for multiple sclerosis at 11q23.3 locus is associated with expansion of CXCR5+ circulating regulatory T cells
Journal of Clinical Medicine, Vol. 9, Núm. 3
-
NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients
Brain : a journal of neurology, Vol. 143, Núm. 5, pp. 1414-1430